{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006915",
      "entity_text" : "apoptosis",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pfam:PF06589",
      "entity_text" : "CRA",
      "entity_type" : "family"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In the present study, the following results were observed : i) CRA inhibited cardiac fibrosis and improved left ventricular dysfunction following MI; ii) CRA reduced the production of ROS, which was associated with regulating the activity of the AMPKalpha/Nrf2/HO-1 signalling pathway and Noxs, particularly Nox2 and Nox4; iii) CRA inhibited inflammation and apoptosis caused by MI; and iv) AMPKalpha inhibition reversed the protective effect of CRA.",
  "reading_complete" : "2020-08-03T16:39:19Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T16:38:08Z",
  "trigger" : "inhibited",
  "evidence" : [ "CRA inhibited inflammation and apoptosis" ],
  "pmc_id" : "7138284",
  "score" : 0
}